Deborah Clarke

927 total citations
20 papers, 719 citations indexed

About

Deborah Clarke is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Deborah Clarke has authored 20 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in Deborah Clarke's work include Epigenetics and DNA Methylation (5 papers), Acute Myeloid Leukemia Research (4 papers) and Zebrafish Biomedical Research Applications (4 papers). Deborah Clarke is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Acute Myeloid Leukemia Research (4 papers) and Zebrafish Biomedical Research Applications (4 papers). Deborah Clarke collaborates with scholars based in United Kingdom, United States and Netherlands. Deborah Clarke's co-authors include Constanze Bonifer, Hiromi Tagoh, Richard Ingram, Daniel G. Tenen, David Hume, Georges Lacaud, Arthur D. Riggs, Monika Lichtinger, Pieter J. M. Leenen and Valérie Kouskoff and has published in prestigious journals such as Genes & Development, The EMBO Journal and Blood.

In The Last Decade

Deborah Clarke

20 papers receiving 705 citations

Peers

Deborah Clarke

IMMUN

HEMAT

ONCOL

Farshid Radparvar United States

M Allouche France

T Hoang Canada

Luisella Luchetti Italy

Janet J. Bijl Canada

Jun Mo United States

Michael Lutteropp United Kingdom

Munetake Shimabe Japan

Qian‐Lin Hao United States

Alena Malyukova Sweden

Farshid Radparvar United States

Deborah Clarke

473 ×1.1

169 ×0.6

IMMUN

199 ×1.2

HEMAT

141 ×1.1

ONCOL

89 ×0.7

Citations per year, relative to Deborah Clarke Deborah Clarke (= 1×) peers Farshid Radparvar

Countries citing papers authored by Deborah Clarke

Since Specialization

Citations

This map shows the geographic impact of Deborah Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Clarke more than expected).

Fields of papers citing papers by Deborah Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Clarke. The network helps show where Deborah Clarke may publish in the future.

Co-authorship network of co-authors of Deborah Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Clarke. A scholar is included among the top collaborators of Deborah Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Clarke. Deborah Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ryan, Liam, et al.. (2021). Coprocytobiology: A Technical Review of Cytological Colorectal Cancer Screening in Fecal Samples. SLAS TECHNOLOGY. 26(6). 591–604. 3 indexed citations

Macrae, Fraser L., Stephen R. Baker, Peter Hillmen, et al.. (2020). Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab. American Journal of Hematology. 95(8). 944–952. 6 indexed citations

Gilmour, Jane, Salam A. Assi, Harmen J.G. van de Werken, et al.. (2014). A crucial role for the ubiquitously expressed transcription factor Sp1 at early stages of hematopoietic specification. Development. 141(12). 2391–2401. 53 indexed citations

Lichtinger, Monika, Richard Ingram, Rebecca Hannah, et al.. (2012). RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. The EMBO Journal. 31(22). 4318–4333. 136 indexed citations

Ingram, Richard M., Nicola K. Wilson, Mohamed Amine Bouhlel, et al.. (2011). Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5. Experimental Hematology. 39(7). 730–740.e2. 3 indexed citations

Walter, Korden, Peter N. Cockerill, Rachael Barlow, et al.. (2010). Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5. Oncogene. 29(20). 2927–2937. 22 indexed citations

Hoogenkamp, Maarten, Monika Lichtinger, Christophe Lancrin, et al.. (2009). Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood. 114(2). 299–309. 97 indexed citations

Chen, Jieping, Deborah Clarke, & Constanze Bonifer. (2007). Reduced c-myb Expression Levels Affect Hematopoietic Development In Vitro. International Journal of Hematology. 85(4). 312–316. 2 indexed citations

Hoogenkamp, Maarten, Richard Ingram, Gang Huang, et al.. (2007). The Pu.1 Locus Is Differentially Regulated at the Level of Chromatin Structure and Noncoding Transcription by Alternate Mechanisms at Distinct Developmental Stages of Hematopoiesis. Molecular and Cellular Biology. 27(21). 7425–7438. 53 indexed citations

10.

Tagoh, Hiromi, Richard Ingram, Nicola K. Wilson, et al.. (2006). The mechanism of repression of the myeloid‐specific c‐fms gene by Pax5 during B lineage restriction. The EMBO Journal. 25(5). 1070–1080. 49 indexed citations

11.

Coletta, P. Louise, Albrecht Müller, Elena Jones, et al.. (2003). Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood. 103(3). 1050–1058. 48 indexed citations

12.

Tagoh, Hiromi, Deborah Clarke, Pieter J. M. Leenen, et al.. (2002). Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells. Genes & Development. 16(13). 1721–1737. 104 indexed citations

13.

Banks, Rosamonde E., M A Forbes, Poulam M. Patel, et al.. (2000). SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS. Cytokine. 12(4). 388–396. 14 indexed citations

14.

Davies, Faith E., Andy C. Rawstron, Guy Pratt, et al.. (2000). Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests. Hematological Oncology. 18(3). 111–120. 3 indexed citations

15.

Clarke, Deborah, et al.. (2000). In vitro differentiation of c-myb−/− ES cells reveals that the colony forming capacity of unilineage macrophage precursors and myeloid progenitor commitment are c-Myb independent. Oncogene. 19(30). 3343–3351. 32 indexed citations

16.

Stevenson, Alexander J., Deborah Clarke, David M. Meredith, et al.. (2000). Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro. Gene Therapy. 7(6). 464–471. 22 indexed citations

17.

Clarke, Deborah, Peter Johnson, Rosamonde E. Banks, et al.. (1996). EFFECTS OF INTERLEUKIN 6 ADMINISTRATION ON PLATELETS AND HAEMOPOIETIC PROGENITOR CELLS IN PERIPHERAL BLOOD. Cytokine. 8(9). 717–723. 29 indexed citations

18.

Gordon, M. Y., et al.. (1990). Haemopoietic stem cell subpopulations in mouse and man: discrimination by differential adherence and marrow repopulating ability.. PubMed. 5 Suppl 1. 6–8. 11 indexed citations

19.

Balner, H., et al.. (1962). PROLIFERATION AND REJECTION OF TRANSPLANTED TRITIUM LABELED BONE MARROW CELLS IN MICE. Plastic & Reconstructive Surgery. 29(4). 427–434. 5 indexed citations

20.

Balner, H., L. J. Old, & Deborah Clarke. (1962). Accelerated Rejection of Male Skin Isografts by Female G57BL Mice Infected with Bacillus Calmette-Guerin (B.C.G.).. Experimental Biology and Medicine. 109(1). 58–62. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact